Clinical Trial Update: AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating AK104 plus radiotherapy with standard therapy as first-line treatment for microsatellite-stable colorectal cancer with liver metastases…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer with Liver Metastases

Drugs mentioned

• AK104 (PD-1/CTLA-4 bispecific antibody)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer Liver Metastases (CRLM) | Phase 2 | Status: RECRUITING